Comparison the Antibacterial Activity of Vitamin D2 and D3
Keywords:vitamin D, pathogenigc bacteria, antibacterial
AbstractAn attempt has been made to determine the antimicrobial activity of vitamin D; D3 & D2 against clinical bacterial isolates as well as perform a comparative analytical study between the effects of both forms of vitamin. The ability of vitamin D (both D2 ergocalciferol& D3 cholecalciferol ) to inhibit bacterial growth of some clinical isolates have been tested . Forty - three pathogenic bacterial isolates (Gr+ ,Gr- ) have been identified from fifty - five specimen was collected from different sources ; 24 urine, 17 sputum , 9 blood , 5 skin at Al-Kindey hospital for a period of two months . Antibiotic sensitivity was carried out towards 12 different antibiotic discs. The most resistant isolates have been chosen to be tested in the study. Two bacterial suspensions of the selected isolates have been prepared; the first was adjusted to McFarland standard No. 0.5 (1 ×10 8 CFU /mL); the second = 1×1010 CFU /mL. Three concentrations of both vitamins have been prepared; 50,000, 70,000 and 90,000 IU/mL as well as the control ( solvent only ). Antibacterial activity has been examined by using agar diffusion (pore plating method) to determine the most effective concentration among the three concentrations of the two forms of vitamin D. Results were suggesting the important role of vitamin D specially D3 as antibacterial agent .The third concentration (90,000) IU/mL was causing the largest inhibition zone with all tested isolates even with the high turbidity culture (1010CFU/mL) ,followed by the second one (70,000) IU/mL, the lower inhibitor concentration was (50,000) IU/mL. Significant differences have been appeared among the measurements of the diameters of inhibition zones towards three vitamin concentrations when compared one to another and to control.
PubChem-Open database 2014.
Gombart AF. The vitamin D-antimicrobial peptide pathway and its role in protection against infectionFuture Microbiol.;4:1151–1165.2009 .
Mostafa WZ and HegazyRA .2014 .Vitamin D and the skin: Focus on a complex relationship: A review.Journal of Biotechnology Research. Open Access funded by Ministry of Science & Technology, Egypt Under a Creative Commons licens. Copyright © Elsevier B.V. 2015.
Greenstein, RJIs Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis 3: 507–514.2003 .
Greenstein, R.J.; Su, L. and Brown, S.T. Vitamins A & D Inhibit the Growth of Mycobacteria in Radiometric Culture. PLoS ONE 7(1)2012 .
Ranji SR, Steinman MA, Shojania KG, Gonzales R. Interventions to reduce unnecessary antibiotic prescribing: a systematic review and quantitative analysis. Med Care.;46:847–862.2008.
Gua C.and Gombart A. The Antibiotic Effects of Vitamin D.End- ocrine,Metabolic & Immune Disorders-Drug Targets Vol 14,Issue 4, Pages 255266(12).2014.
Shapira Y, Agmon-Levin N, Shoenfeld Y. Mycobacterium tuberculosis, autoimmunity and vitamin D. Clin Rev Allergy Immunol.;38:169– 177.2010.
Coussens AK ;Martioeau AR and Wilkinson RJ : Anti-Inflammatory and Antimicrobial Actions of Vitamin D in Combating TB/HIV.Scientifica.vol .2014.
Cannell JJ, Hollis BW. Use of vitamin D in clinical practice.Altern Med Rev.;13:6–20.2008.
Osol, A. and J.E. Hoover, etal. (eds.) Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., p. 943.1975.  NCBI National Center for Biotechnology Information.USA.2012.
Novak, K.M .Drug Facts and Comparisons (56th ed.).St. Louis,Missouri: Wolters Kluwer Health.p.619.ISBN 1-57439-110 .2002.
Feindt E, Stroder J. Studies on the antimicrobial effect of vitamin D. KlinWochenschr.55:507– 508.1977.  CLSI (Clinical and Laboratory Standards Institute). Performance Standard for Antimicrobial Susceptibility Testing ;Twenty –First Informational Supplement .,M100-S21.31(1).2011.
Microsoft Excel 2007/XP or Sigmaplot 12.
Nutanbala NG.;Hiren R.L; AlpeshP.P;Goswami T.K :Antibiotic Sensitivity Profile of Bacterial Pathogens in Postoperative Wound Infections at a Tertiary Care Hospital in Gujarat, india .J.Pharmacol.Pharmacother. Jul-Sep;2(3):158164.2011.
Mwambete K. D. and Nyaulingo B: Antibiotic Resistance Profiles of Bacterial Pathogens from Private hospitals in Dar es Salaam, Tanzania .International Journal of pharmacy and pharmaceutical sciences.
Matheson EM, Mainous AG, 3rd, Hueston WJ, Diaz VA, Everett CJ. Vitamin D and methicillinresistant Staphylococcus aureus nasal carriage.Scand J Infect Dis.;42:455–460.2010.
Holick MF. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets;12:4– 18. 2011.
Bartley J. Vitamin D: emerging roles in infection and immunity. Expert Rev Anti Infect Ther.;8:1359–1369.2010.
Ginde AA, Mansbach JM, Camargo CA., Jr Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med.;169:384–390.2009.
Schwalfenberg GK. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency.MolNutr Food Res. 55:96–108.2011.
Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR, et al. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med.7:28.2009.
Manaseki-Holland S, Qader G, Isaq Masher M, Bruce J, Zulf Mughal M, Chandramohan D, et al. . Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop Med Int Health;15:1148– 1155. 2010.
Agak GW, Qin M, Nobe J, Kim MH, Krutzik SR, Tristan GR,et al. Propionibacteriumacnesinduces an IL-17 response in acne vulgaris that is regulated by vitamin A and vitamin D. J Invest Dermatol .134(2):366–73. 2014.
Al-salihDA ; Aziz FM; Mshimesh BAR; Jehad MT (2013) :Antibacterial Effect vitamin E :in vitro study .J. Biotechnology Research center .7(2) :1723.
Valverde LF, Cedillo FD, Reyes GC , Ramos ML . Synthesis and Antibacterial Activity of Pregnenolone-Vitamin B1 Conjugate Vol I: Issue3: Nov-Dec ;International Journal of Applied and Pharmaceutical Technology Page: 915, 2010.
How to Cite
The journal has no restrictions for the author to hold the copyrights of his articles. The journal does not allow authors to republish the same article in other journals or conferences that is published in one of its volumes.